DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel in Psoriasis.

Information source: Amgen
Information obtained from ClinicalTrials.gov on August 08, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Psoriasis

Intervention: ENBREL (Biological); Enbrel (Drug); ENBREL (Biological)

Phase: Phase 4

Status: Recruiting

Sponsored by: Amgen

Official(s) and/or principal investigator(s):
MD, Study Director, Affiliation: Amgen

Overall contact:
Amgen Call Center, Phone: 866-572-6436

Summary

The purpose of this study is to evaluate the use of EnbrelŪ (etanercept) in the treatment of psoriasis in patients for a period of up to 1 year.

Clinical Details

Official title: Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel in Psoriasis

Study design: Treatment, Non-Randomized, Open Label, Single Group Assignment, Safety/Efficacy Study

Primary outcome: PHYSICIAN GLOBAL ASSESSMENT

Secondary outcome: QOL, Safety

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria: - 18 years of age or older Moderate to severe plaque psoriasis Able to

start Enbrel therapy per the approved product monograph Exclusion Criteria Active infections Evidence of skin conditions other than psoriasis that would interfere with study evaluations Subjects receiving Remicade (infliximab), Humira (adalimumab) or Amevive (alefacept)

Locations and Contacts

Amgen Call Center, Phone: 866-572-6436

Research Site, Quebec, Canada; Recruiting

Research Site, Edmonton, Alberta, Canada; Completed

Research Site, Calgary, Alberta, Canada; Recruiting

Research Site, Vancouver, British Columbia, Canada; Recruiting

Research Site, Nanaimo, British Columbia, Canada; Recruiting

Research Site, Winnipeg, Manitoba, Canada; Recruiting

Research Site, SaintJohn, New Brunswick, Canada; Recruiting

Research Site, Moncton, New Brunswick, Canada; Recruiting

Research Site, St. John's, Newfoundland and Labrador, Canada; Recruiting

Research Site, Halifax, Nova Scotia, Canada; Recruiting

Research Site, Nepean, Ontario, Canada; Completed

Research Site, Markham, Ontario, Canada; Recruiting

Research Site, London, Ontario, Canada; Recruiting

Research Site, Milton, Ontario, Canada; Recruiting

Research Site, Toronto, Ontario, Canada; Recruiting

Research Site, Windsor, Ontario, Canada; Recruiting

Research Site, Oakville, Ontario, Canada; Recruiting

Research Site, Richmond Hill, Ontario, Canada; Recruiting

Research Site, Ottawa, Ontario, Canada; Recruiting

Research Site, NorthYork, Ontario, Canada; Recruiting

Research Site, Barrie, Ontario, Canada; Recruiting

Research Site, Burlington, Ontario, Canada; Completed

Research Site, Mississauga, Ontario, Canada; Recruiting

Research Site, Hamilton, Ontario, Canada; Recruiting

Research Site, Sarnia, Ontario, Canada; Recruiting

Research Site, Newmarket, Ontario, Canada; Recruiting

Research Site, Laval, Quebec, Canada; Completed

Research Site, Sherbrooke, Quebec, Canada; Recruiting

Research Site, Montreal, Quebec, Canada; Recruiting

Research Site, Ste-Anne, Quebec, Canada; Recruiting

Additional Information

AmgenTrials clinical trials website

Starting date: March 2006
Ending date: August 2009
Last updated: July 24, 2008

Page last updated: August 08, 2008

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014